The effect of islet cell mass and timing of ALS administration on pancreatic allograft survival.
D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D001803:Blood Transfusion; D001835:Body Weight; D003921:Diabetes Mellitus, Experimental / Q000628:therapy; D005260:Female; D006085:Graft Survival; D007515:Islets of Langerhans / Q000033:anatomy & histology; D016381:Islets of Langerhans Transplantation; D008297:Male; D009924:Organ Culture Techniques; D051381:Rats; D011912:Rats, Inbred ACI; D011919:Rats, Inbred Strains
D000961:Antilymphocyte Serum